GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients with Nonalcoholic Fatty Liver Disease

BACKGROUND AND AIMS: De novo lipogenesis is increased in livers of patients with nonalcoholic steatohepatitis (NASH). Acetyl-CoA carboxylase catalyzes the rate-limiting step in this process. We evaluated the safety and efficacy of GS-0976, an inhibitor of acetyl-CoA carboxylase in liver, in a phase...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterology
Main Authors: Loomba, Rohit, Kayali, Zeid, Noureddin, Mazen, Ruane, Peter, Lawitz, Eric J., Bennett, Michael, Wang, Lulu, Harting, Eliza, Tarrant, Jacqueline M., McColgan, Bryan J., Chung, Chuhan, Ray, Adrian S., Subramanian, G. Mani, Myers, Robert P., Middleton, Michael S., Lai, Michelle, Charlton, Michael, Harrison, Stephen A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6318218/
https://ncbi.nlm.nih.gov/pubmed/30059671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2018.07.027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados